Status:
RECRUITING
Respiratory Muscle Strength and Aerobic Capacity in Scleroderma
Lead Sponsor:
Firat University
Conditions:
Scleroderma
Eligibility:
FEMALE
18-65 years
Brief Summary
Primary aim of this study was to compare respiratory muscle strength, aerobic capacity, dyspnea, pulmonary function tests and fatigue values with healthy controls. The secondary aim was to evaluate th...
Detailed Description
Scleroderma is a systemic connective tissue disease characterized by progressive thickening of the skin, the etiology of which has not been fully elucidated, in which microvascular damage, immune acti...
Eligibility Criteria
Inclusion
- Being diagnosed with Ssk according to ACR/EULAR criteria
- Stable medical treatment for 3 months
Exclusion
- Having a regular exercise habit (doing regular exercise at least once a week for the last 3 months)
- Comorbidity with another chronic disease that may affect aerobic capacity or respiratory muscle strength
- Having concomitant acute respiratory diseases
- Having a smoking habit
- History of orthopedic or neurologic disease in the lower extremities that may prevent cycling
Key Trial Info
Start Date :
August 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06554132
Start Date
August 20 2024
End Date
October 30 2024
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Songul Baglan Yentur
Elâzığ, Turkey (Türkiye), 23100